Prevalence of treated epilepsy in Korea based on national health insurance data

Journal of Korean Medical Science

Volumn 27, Issue 3, 2012, Pages 285-290

  Lee, Seo Young ^a   Jung, Ki Young ^b   Lee, Il Keun ^c   Yi, Sang Do ^d   Cho, Yong Won ^d   Kim, Dong Wook ^e   Hwang, Seung Sik ^f   Kim, Sejin ^g   The Korean Epilepsy Society, ^h  

^a Kangwon National University   (South Korea)

^b Korea University Ansan Hospital   (South Korea)

^c Seoul Brain Neurology Clinic   (South Korea)

^d Dongsan Medical Center   (South Korea)

^e Konkuk University Hospital   (South Korea)

^f Inha University School of Medicine   (South Korea)

^g Health Insurance Review Agency   (South Korea)

^h NONE

Author keywords

Anticonvulsant; Cost; Epidemiology; Epilepsy; Insurance, health; Prevalence

Indexed keywords

ANTICONVULSIVE AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; ECONOMICS; EPILEPSY; FEMALE; HEALTH CARE COST; HUMAN; INFANT; MALE; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; PUBLIC HEALTH; SEIZURE; SOCIOECONOMICS; SOUTH KOREA; STATISTICS;

ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; EPILEPSY; FEMALE; HEALTH CARE COSTS; HEALTH EXPENDITURES; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; REPUBLIC OF KOREA; SEIZURES; SOCIOECONOMIC FACTORS; YOUNG ADULT;

EID: 84863233350     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2012.27.3.285     Document Type: Article

References (30)

1. Banerjee PN, Filippi D, Allen Hauser W. The descriptive epidemiology of epilepsy: a review. Epilepsy Res 2009; 85: 31-45.
2. Lim SJ, Kim HJ, Nam CM, Chang HS, Jang YH, Kim S, Kang HY. Socioeconomic costs of stroke in Korea: estimated from the Korea national health insurance claims database. J Prev Med Public Health 2009; 42: 251-60.
3. Kim NH, Kim HJ, Cheong HK, Kim BJ, Lee KH, Kim EH, Kim EA, Kim S, Park MS, Yoon WT; Korean Multiple Sclerosis Study Group. Prevalence of multiple sclerosis in Korea. Neurology 2010; 75: 1432-8.
4. Chung W, Oh SM, Suh T, Lee YM, Oh BH, Yoon CW. Determinants of length of stay for psychiatric inpatients: analysis of a national database covering the entire Korean elderly population. Health Policy 2010; 94: 120-8.
5. Kang HY, Yang KH, Kim YN, Moon SH, Choi WJ, Kang DR, Park SE. Incidence and mortality of hip fracture among the elderly population in South Korea: a population-based study using the national health insurance claims data. BMC Public Health 2010; 10: 230.
6. Park CS, Kang HY, Kwon I, Kang DR, Jung HY. Cost-of-illness study of asthma in Korea: estimated from the Korea National Health insurance claims database. J Prev Med Public Health 2006; 39: 397-403.
7. Lee JH, Park YS, Choi JS. The epidemiology of appendicitis and appendectomy in South Korea: national registry data. J Epidemiol 2010; 20: 97-105.
8. Wallace H, Shorvon S, Tallis R. Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of 2,052,922 and age-specific fertility rates of women with epilepsy. Lancet 1998; 352: 1970-3.
9. Sillanpää M, Kälviäinen R, Klaukka T, Helenius H, Shinnar S. Temporal changes in the incidence of epilepsy in Finland: nationwide study. Epilepsy Res 2006; 71: 206-15.
10. Christensen J, Vestergaard M, Pedersen MG, Pedersen CB, Olsen J, Sidenius P. Incidence and prevalence of epilepsy in Denmark. Epilepsy Res 2007; 76: 60-5.
11. Kurth T, Lewis BE, Walker AM. Health care resource utilization in patients with active epilepsy. Epilepsia 2010; 51: 874-82.
12. Korean National Health Insurance Cooperation. Annual report of national health insurance statistics, 2007. Seoul: Division of statistical analysis, Korean National Health Insurance Cooperation, 2007.
13. Statistics Korea. Population trends. Office for Social Statistics, Statistics Korea, 2007.
14. OECD. OECD Health Data 2009. Paris: OECD, 2009.
15. Cockerell OC, Hart YM, Sander JW, Shorvon SD. The cost of epilepsy in the United Kingdom: an estimation based on the results of two population-based studies. Epilepsy Res 1994; 18: 249-60.
16. Yoon D, Frick KD, Carr DA, Austin JK. Economic impact of epilepsy in the United States. Epilepsia 2009; 50: 2186-91.
17. Fisher RS, van Emde Boas W, Blume W, Elger C, Genton P, Lee P, Engel J Jr. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 2005; 46: 470-2.
18. Sridharan R, Murthy BN. Prevalence and pattern of epilepsy in India. Epilepsia 1999; 40: 631-6.
19. Tuan NA, Cuong le Q, Allebeck P, Chuc NT, Persson HE, Tomson T. The prevalence of epilepsy in a rural district of Vietnam: a population-based study from the EPIBAVI project. Epilepsia 2008; 49: 1634-7.
20. Forsgren L, Beghi E, Oun A, Sillanpää M. The epidemiology of epilepsy in Europe: a systematic review. Eur J Neurol 2005; 12: 245-53.
21. Keränen T, Riekkinen PJ, Sillanpää M. Incidence and prevalence of epilepsy in adults in eastern Finland. Epilepsia 1989; 30: 413-21.
22. Haerer AF, Anderson DW, Schoenberg BS. Prevalence and clinical features of epilepsy in a biracial United States population. Epilepsia 1986; 27: 66-75.
23. Heaney DC, MacDonald BK, Everitt A, Stevenson S, Leonardi GS, Wilkinson P, Sander JW. Socioeconomic variation in incidence of epilepsy: prospective community based study in south east England. BMJ 2002; 325: 1013-6.
24. Hesdorffer DC, Tian H, Anand K, Hauser WA, Ludvigsson P, Olafsson E, Kjartansson O. Socioeconomic status is a risk factor for epilepsy in Icelandic adults but not in children. Epilepsia 2005; 46: 1297-303.
25. Kong Y, Cho SY, Cho MS, Kwon OS, Kang WS. Seroepidemiological observation of Taenia solium cysticercosis in epileptic patients in Korea. J Korean Med Sci 1993; 8: 145-52.
26. Statistics Korea. Local income. Office for Economic Statistics, Statistics Korea, 2007.
27. Harden CL, Meador KJ, Pennell PB, Hauser WA, Gronseth GS, French JA, Wiebe S, Thurman D, Koppel BS, Kaplan PW, Robinson JN, Hopp J, Ting TY, Gidal B, Hovinga CA, Wilner AN, Vazquez B, Holmes L, Krumholz A, Finnell R, Hirtz D, Le Guen C; American Academy of Neurology, American Epilepsy Society. Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review): II. Teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Epilepsia 2009; 50: 1237-46.
28. Morrow J, Russell A, Guthrie E, Parsons L, Robertson I, Waddell R, Irwin B, McGivern RC, Morrison PJ, Craig J. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 2006; 77: 193-8.
29. French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks WJ Jr, Turk WR, Fischer JH, Bourgeois B, Wilner A, Faught RE Jr, Sachdeo RC, Beydoun A, Glauser TA; American Academy of Neurology Therapeutics and Technology Assessment Subcommittee, American Academy of Neurology Quality Standards Subcommittee, American Epilepsy Society Quality Standards Subcommittee, American Epilepsy Society Therapeutics and Technology Assessment Subcommittee. Efficacy and tolerability of the new antiepileptic drugs. I: Treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society. Epilepsia 2004; 45: 401-9.
30. Strzelczyk A, Reese JP, Dodel R, Hamer HM. Cost of epilepsy: a systematic review. Pharmacoeconomics 2008; 26: 463-76.